Vaccine Information: Pfizer-BioNTech Covid-19 Vaccine (Page 6 of 6)

PRINCIPAL DISPLAY PANEL — 1.8 mL Vial Label

Pfizer-BioNTech COVID-19 Vaccine
After dilution, vial contains 6 doses of 0.3 mL

For intramuscular use. Contains no preservative.

For use under Emergency Use Authorization.

DILUTE BEFORE USE. Discard 6 hours afterdilution when stored at 2 to 25°C (35 to 77°F).

Dilution date and time:

NDC 59267-1000-1

PRINCIPAL DISPLAY PANEL — 195 Vial Carton Label

NDC 59267-1000-2

Pfizer-BioNTech COVID-19 Vaccine
Suspension for Intramuscular Injection

195 Multiple Dose Vials
(after dilution each vial contains
6 doses of 0.3 mL)

Pfizer BIONTECH

STORAGE: Prior to dilution, store at
-80°C to -60°C (-112°F to -76°F).
Store in this carton to protect from light.

DOSAGE AND ADMINISTRATION: After
dilution, each vial contains 6 doses of 0.3 mL.
See FDA-authorized Fact Sheet or scan
QR code for information.

MUST BE DILUTED BEFORE USE with sterile
0.9% Sodium Chloride Injection, USP (not supplied).
After dilution, store the vaccine at 2°C to 25°C (35°F to 77°F).
Discard after 6 hours.
Contains no preservative.
For use under Emergency Use Authorization.
Rx only

Manufactured by
Pfizer Inc
New York, NY 10017

Manufactured for
BioNTech
Manufacturing GmbH
An der Goldgrube 1255131 Mainz, Germany

PAA166261

LOT:

EXP:

PRINCIPAL DISPLAY PANEL — 25 Vial Carton

NDC 59267-1000-3
Rx only

Pfizer-BioNTech COVID-19 Vaccine
Suspension for Intramuscular Injection

25 Multiple Dose Vials
(after dilution each vial contains 6 doses of 0.3 mL)

MUST BE DILUTED BEFORE USE with sterile
0.9% Sodium Chloride Injection, USP (not supplied).
After dilution, store the vaccine at 2°C to 25°C (35°F to 77°F).Discard after 6 hours.

PFIZER-BIONTECH COVID-19 VACCINE bnt162b2 injection, suspension

Product Information Product Type VACCINE Item Code (Source) NDC:59267-1000 Route of Administration INTRAMUSCULAR DEA Schedule

Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength TOZINAMERAN (TOZINAMERAN) TOZINAMERAN 0.225 mg in 2.25 mL

Inactive Ingredients Ingredient Name Strength ALC-0159 ALC-0315 POTASSIUM CHLORIDE MONOBASIC POTASSIUM PHOSPHATE SODIUM CHLORIDE SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM SUCROSE

Packaging # Item Code Package Description Multilevel Packaging 1 NDC:59267-1000-2 195 VIAL, GLASS in 1 CARTON contains a VIAL, GLASS (59267-1000-1) 1 NDC:59267-1000-1 2.25 mL in 1 VIAL, GLASS This package is contained within the CARTON (59267-1000-2) 2 NDC:59267-1000-3 25 VIAL, GLASS in 1 CARTON contains a VIAL, GLASS (59267-1000-1) 2 NDC:59267-1000-1 2.25 mL in 1 VIAL, GLASS This package is contained within the CARTON (59267-1000-3)

Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date UNAPPROVED DRUG OTHER 12/12/2020

Labeler — Pfizer Manufacturing Belgium NV (370156507)

Registrant — Pfizer Inc (113480771)

Establishment
Name	Address	ID/FEI	Operations
Pfizer Manufacturing Belgium NV		370156507	ANALYSIS (59267-1000), MANUFACTURE (59267-1000), PACK (59267-1000), LABEL (59267-1000)

Establishment
Name	Address	ID/FEI	Operations
Pharmacia & Upjohn Company LLC		618054084	ANALYSIS (59267-1000), MANUFACTURE (59267-1000), PACK (59267-1000), LABEL (59267-1000)

Establishment
Name	Address	ID/FEI	Operations
Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC		174350868	ANALYSIS (59267-1000), API MANUFACTURE (59267-1000)

Establishment
Name	Address	ID/FEI	Operations
Pfizer Inc		004954111	ANALYSIS (59267-1000)

Revised: 04/2021 Pfizer Manufacturing Belgium NV